Financials
- Market Capitalization 1.49 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14.67
Relación precio/flujo de caja
1 072.51
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2179 | NVAX Novavax, Inc. - Common Stock | 9.26 USD | +2.32% | +4.28% | +24.46% | +25.30% | 1.53 B USD | ||
| 2184 | INVA Innoviva, Inc. - Common Stock | 20.97 USD | +0.05% | -0.47% | -0.47% | +17.68% | 1.51 B USD | ||
| 2195 | TYRA Tyra Biosciences, Inc. - Common Stock | 24.94 USD | -4.55% | -4.04% | -24.56% | +73.92% | 1.49 B USD | ||
| 2198 | AVBP ArriVent BioPharma, Inc. - Common Stock | 30.17 USD | -2.68% | +3.96% | -1.50% | +55.92% | 1.49 B USD |